Back to Dashboard
NVZMY · Basic Materials

Novozymes A/s

Europe Basic Materials
Market cap
$30.2B
Industry
Specialty Chemicals
Sector
Basic Materials
Exchange
OTC Markets OTCPK
About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification,…

Congressional trades · 6 on record
Disclosures from 2019-06-24 to 2026-06-01
Trade date Member Chamber Action Amount
2026-06-01 Josh Gottheimer · D-NJ House Sold $1,001 - $15,000
2021-02-17 Peter Meijer · R-MI House Sold $1,001 - $15,000
2020-08-04 Greg Gianforte · R-MT House Sold $15,001 - $50,000
2020-03-18 Greg Gianforte · R-MT House Bought $1,001 - $15,000
2020-01-13 Greg Gianforte · R-MT House Bought $15,001 - $50,000
2019-06-24 Donna E. Shalala · D-FL House Sold $1,001 - $15,000
Not in our coverage. Novozymes A/S isn't currently held by any of the 50 hedge funds we track. The price chart and company profile below come from public Yahoo Finance data.
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell Novozymes A/S or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime